Simplex Trading’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-18,600
| Closed | -$461K | – | 9413 |
|
|
2026
Q1 | $461K | Buy |
+18,600
| New | +$443K | ﹤0.01% | 3360 |
|
|
2025
Q4 | – | Sell |
-8,800
| Closed | -$173K | – | 8768 |
|
|
2025
Q3 | $173K | Buy |
8,800
+800
| +10% | +$16.5K | ﹤0.01% | 5116 |
|
|
2025
Q2 | $173K | Buy |
8,000
+6,400
| +400% | +$151K | ﹤0.01% | 4654 |
|
|
2025
Q1 | $38K | Buy |
1,600
+1,400
| +700% | +$31.5K | ﹤0.01% | 6044 |
|
|
2024
Q4 | $4K | Sell |
200
-2,800
| -93% | -$60.2K | ﹤0.01% | 7712 |
|
|
2024
Q3 | $59K | Buy |
3,000
+2,700
| +900% | +$50.1K | ﹤0.01% | 5742 |
|
|
2024
Q2 | $4K | Sell |
300
-30,700
| -99% | -$478K | ﹤0.01% | 7963 |
|
|
2024
Q1 | $494K | Buy |
+31,000
| New | +$467K | ﹤0.01% | 3875 |
|
|
2023
Q4 | – | Sell |
-1,600
| Closed | -$18K | – | 8908 |
|
|
2023
Q3 | $18K | Sell |
1,600
-12,200
| -88% | -$163K | ﹤0.01% | 6698 |
|
|
2023
Q2 | $185K | Buy |
13,800
+7,500
| +119% | +$108K | ﹤0.01% | 4382 |
|
|
2023
Q1 | $104K | Buy |
6,300
+1,000
| +19% | +$16.5K | ﹤0.01% | 5107 |
|
|
2022
Q4 | $98K | Sell |
5,300
-25,100
| -83% | -$386K | ﹤0.01% | 5094 |
|
|
2022
Q3 | $390K | Buy |
30,400
+29,300
| +2,664% | +$347K | ﹤0.01% | 3757 |
|
|
2022
Q2 | $7K | Sell |
1,100
-32,900
| -97% | -$241K | ﹤0.01% | 8565 |
|
|
2022
Q1 | $281K | Buy |
34,000
+33,200
| +4,150% | +$235K | ﹤0.01% | 4638 |
|
|
2021
Q4 | $5K | Sell |
800
-83,400
| -99% | -$548K | ﹤0.01% | 9500 |
|
|
2021
Q3 | $487K | Hold |
84,200
| – | – | ﹤0.01% | 4146 |
|
|
2021
Q2 | $484K | Buy |
84,200
+84,065
| +62,270% | +$434K | ﹤0.01% | 4223 |
|
|
2021
Q1 | $62K | Sell |
135
-31
| -19% | -$123 | ﹤0.01% | 6342 |
|
|
2020
Q4 | $55K | Buy |
166
+58
| +54% | +$195 | ﹤0.01% | 6068 |
|
|
2020
Q3 | $32K | Sell |
108
-25
| -19% | -$98 | ﹤0.01% | 6005 |
|
|
2020
Q2 | $61K | Buy |
133
+29
| +28% | +$130 | ﹤0.01% | 5309 |
|
|
2020
Q1 | $40K | Buy |
104
+5
| +5% | +$21 | ﹤0.01% | 5354 |
|
|
2019
Q4 | $37K | Sell |
99
-183
| -65% | -$856 | ﹤0.01% | 5466 |
|
|
2019
Q3 | $149K | Sell |
282
-211
| -43% | -$1.12K | ﹤0.01% | 3876 |
|
|
2019
Q2 | $189K | Sell |
493
-13
| -3% | -$56 | ﹤0.01% | 3515 |
|
|
2019
Q1 | $258K | Buy |
+506
| New | +$1.49K | ﹤0.01% | 3332 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$1K | – | 7097 |
|
|
2018
Q3 | $1K | Buy |
+4
| New | +$13 | ﹤0.01% | 7176 |
|
Other funds holding CPRX
GCL
HI
Simplex Trading's CPRX Position: Q2 2026 in Review
Simplex Trading sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 3,811 shares — an estimated $112K sold.
Simplex Trading first reported a position in CPRX in Q4 2014 and held it in 30 quarters. The position peaked at $448K in Q3 2021. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Simplex Trading reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 3,811 Catalyst Pharmaceutical shares in Q2 2026, an estimated $112K.
- Simplex Trading first reported a position in Catalyst Pharmaceutical in Q4 2014 and held it in 30 quarters.
- Simplex Trading's Catalyst Pharmaceutical position peaked at $448K in Q3 2021.
- 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.